UK doctors think Britain’s exit from the European Union will be very bad for the NHS, reveal the results of a study from UCL, the London School of Hygiene & Tropical Medicine (LSHTM) and Queen Mary University of London.
IMI’s RADAR-CNS project is evaluating how wearable devices and smartphone technology could be used to monitor major depressive disorder, epilepsy, and multiple sclerosis. The project has now launched studies in all three disease areas; the results will ultimately make it easier to predict and hopefully prevent relapses, thereby dramatically improving patients’ quality of life.
An Antimicrobial Resistance (AMR) Accelerator Programme is part of new IMI Calls for proposals, along with topics on brain disorders, immune-mediated diseases clinical trial design, medicines safety, and blockchain technologies.
At the Euroscience Open Forum conference, a Bulgarian medical start-up demonstrates the potential - and the challenges - of getting health systems to focus on preventing disease, rather than responding when it strikes